Showing posts with label pulmonary. Show all posts
Showing posts with label pulmonary. Show all posts

Wednesday, August 17, 2011

beta blockers in COPD

It has been a looong gap ....moving and starting a fellowship in a new place is a little tough. Anyway I have settled down in my new place now. 
Let me start with a short blog..regarding a discussion between a pulmonary fellow and the primary team that I happened to hear while doing my usual hyponatremia consult!
Traditionally betablockers were not used in patients with COPD or asthma due to bronchospam. But using a cardioselective agent may not afect the airways.But a recent retrospective study in bmj went a step ahead and showed that it may be even beneficial in patients with COPD. 
Of nearly 6000 patients with different stages of COPD ,they found that there was a 22% reduction in all cause mortality from beta blockers. The benifit was shown across all stages of COPD. With regards to lung function, they did not affect FEV1/FVC. also betablockers seemed to have additive benifits on hospital admissions. This benifit was seen independent of presence of cardiovascular disease.

Figure


A somewhat related study published by one of my senior resident(Int J Chron Obst Pulm Disease 2010)  showed that patients with COPD may have unrecognised myocardial injury. May be betablockers help with this and this is what we are seeing here. 
Time to change practice!!

Friday, January 28, 2011

Thursday, January 6, 2011

CT scan for lung cancer screening

The National Lung Cancer Screening trial (NSLT) ..comparing two ways of detecting lung cancer- low dose helical CT Vs regular chest xray was stopped in Nov 2010 , after the results showed a dramatic reduction in mortality!


The trial began in 2002 and involved more than 53,000 current and former heavy smokers(quit within last 15 years) 55 to 74 years of age. Individuals were randomized to undergo screening annually for 3 years with either CT or chest x-rays, and were then followed for another 5 years.
The results, which were reviewed by the trial's Data and Safety Monitoring Board on October 20, show a statistically significant difference in lung cancer mortality in the 2 groups, which led to the trial being halted. There were 354 lung cancer deaths among those who underwent CT screening and 442 among those who underwent chest x-ray.This is a 20% reduction in mortality in patients who underwent screening with CT scan. This is an impressive finding....but the study has not been published yet. Questions do remain......who is at high risk? and who needs CT scan? There will also be a problem with false positivies, as with any other screening test. So will be interesting to see the cut off criteria for doing a screening CT scan.


Thus far, there has been no recommendation for lung cancer screening from any authority, but these new data might be a turning point.  Keeping in mind that Lung cancer is the leading cause of cancer mortality in US  and worldwide....screening will help reduce the associated mortality. But the most important intervention that will reduce mortality will be staying away from Tobacco!!

Friday, October 29, 2010

Evaluating hypoxia - not that tough!

This is one of the most common finding for ICU transfer/admission. And there are many ways to evaluate hypoxia. Lets try and do  a simple way which would cover the common problems causing hypoxia in clinical practice. 
OK……the usual situation will be that you are called to see a patient with reduced O2 saturations on the wards….and an ABG, chest xray has been done and pt is on O2. (If not done, you need these to make a good decision ). While waiting for these to be done ….we can do the most important thing..taking a SHORT focused history and exam (many times this will give us the clue and we can use the test to confirm them). If not..then lets go through the tests

First thing to assess is that whether this hypoxia is due to pulmonary or extrapulmonary causes( sedatives, neuromuscular weakness, central hypoventilation). The A – a gradient will help. It can be  calculated by the formula  PAO2 (  713 x FiO2 ) – PaO2 – PaCo2 – PaCo2/4 .  Normal gradient is <12 and differs with age…so use age/ 4 +4 to correct for age. Ok..back to the evaluation- If A-a gradient is normal then its likely extrapulmonary cause(usually they have resp acidosis). If it is normal then look at PaCo2. If high..that will suggest airway obstructive disease ie. COPD/asthma. If PaCo2 id normal then have a look at the Chest Xray(CXR). If the CXR is normal then its likely to be a Pulmonary embolism (if the history correlates…..give a shot of heparin(Fondaparinux or Enoxaparin) and send the patient for CTA of chest).  If CXR is abnormal and shows a focal infiltrate then its likely to be pneumonia or atelectasis. If  infiltrates are diffuse then there are 2 possibilities – cardiogenic pulmonary edema or non cardiogenic pulmonary edema(ARDS). The ideal way to distinguish them is to do a Pulmonary artery wedge pressure. But this is not done in recent days as it does not seem to improve mortality. So …we have to rely on factors like ECHO(if done already), EKG, CVP and History.  We can try giving a bolus of Frusemide  to see if it helps. Both may get better, but usually patients with CHF might find a quicker relief.  One other  point here….is to always compare this CXR to a previous one(esp when pt. was stable)

Throughout this evaluation ..history will be helpful. I have found it useful ..to go back to the history(mainly the presenting symptoms) when Iam stuck in the process of evaluating these numbers( any numbers!).                      
So to summarise…the order with which we can look at the numbers ..
1.      1. A-a gradient   2. PaCo2   3. Chest Xray  4. EKG,ECHO,JVD,CVP etc
     Whenever  we are stuck….always get back to the history!

Tuesday, September 28, 2010

Urine test can help pulmonologists too!

This is a urine test done to find the presence of the pneumococcal polysaccharide capsule(the antigen) for diagnosing Community acquired pneumonia caused by Streptococcus pneumoniae. The advantage is that the test can be done in 15 min, and so you have a result  quickly.This may help narrow antibiotics quickly. The next question is ..how far is it reliable. Lets see...

In a study done in Newzealand(but urine antigen was tested in Duke Univ, NC!!) urine antigen was checked in pts with pneumonia along with blood and sputum samples.Subjects without pneumonia served as controls. The most important finding was that antigen testing was negative in all the controls. This gives the test....a very high specificity (so if it is positive..then pt is more likely to have pneomococcal pneumonia). It can also be positive in patients with strep throat, urine having strep mitis.

A study from Spain, in 2001, showed that the positivity of the urine antigen test does not differ much between bacteremic and non-bacteremic patients with Strep Pneumo pneumonia. Have to note...that the test was not reliable in pts who had only a presumptive diagnosis of pneumonia.again specificity was 98%.
The next study from Germany compared the urine test in pts with infiltrate Vs those without infiltrate (what we call as exacerbation of COPD!). The detection rate in pts without an infiltrate (i.e COPD exacerbation) was very low..suggesting its not useful in those group of patients. This has been incorporated in the latest ATS guidelines on CAP. (Just peek at page S40 regarding where its useful).
This recent study from Arch of Int Med also showed the usefulness of urine antigen testing. To be more creative and quick..you can even do the rapid antigen test in a blood culture bottle sample with good detection rates.(Clin Micro 2005)

Whats the downside! - Well..not many. We are trying to diagnose the etiology of only a 3rd of CAP. And even in those found to be positive...there is a possibility of another infection(especially in ICU admits).
 The test can be positive upto 5 days after a pneumococcal vaccine.
 Also ...once had a pneumococcal pneumonia...the urine test will be positive for weeks.(so..not useful if pt is readmitted within 3-5 weeks).
Watch out for false positives with Strep mitis (a cause of endocarditis).

Friday, September 24, 2010

A recap of basics - Pulse oximetry

Pulse oximetry - This is easily one of  the most common and most useful tool in everyday Medicine to manage in hospital, nursing home, clinic patients etc.
It tells us what percentage of hemoglobin is saturated with Oxygen- SO2. When measured in arterial blood, we call it SaO2.
Mechanism - Every pulse oximeter has 3 components - 1. a source emitting 2 wavelengths of light- red & infrared   2. receiver receiving these lights after after passing through the finger or ear lobe   3. a unit processing this information.
The Hemoglobin (Hb) in circulation is mostly in the oxidised form(OxyHb) ..and some in reduced form(deoxyHb). OxyHb absorbs red light and deoxy Hb absorbs infrared light. When the oximeter probe is clipped on the finger, the emitter sends the red & infrared signals. These are absorbed by the respective Hbs (OxyHb - red ,& deoxyHb- infrared). The receiver receives the remaining light. The processing unit then calculates the SaO2 by the following formula...
SaO2(SpO2) = Oxy Hb / OxyHb + deoxyHb x 100

Carboxyhb & MetHb - In case of suspected carboxy or meth hemoglobenemia....the calculation is done by adding them to the denominator. CarboxyHb is bright red in color, and absorbs red light(as OxyHb). Now we can understand the reason behind normal SaO2 in patients with high CarboxyHb (poisoning & low levels in smokers). This can be corrected by using an oximeter emitting 4 wavelengths of light instead of two. But its not usually done...due to the rarity of these disorders. 

Venous Vs arterial sats - Well...venous circulation on the finger tip also has oxyHb & deoxyHb. So how does the oximeter differentiate? ...It is designed to pick up signals only from pulsatile wave forms. So we only get a SaO2....not a SvO2. Because of this...it may not be reliable in people with peripheral vascular disease or in patients with severe tricuspid regurgitation (pulsatile veins).

Anemia - Low Hb does not affect SaO2, as it does not measure the amount of Oxygen in Hb, but the percentage of Hb saturated with Oxygen. i.e occupying the Fe-protporphyrin complexes. So even if Hb is 5g/dl,but all 5 g is well saturated with Oxygen..the oximeter will read 100% SaO2. Another point here....anemia also does not affect partial pressure of O2(PaO2). The only parameter anemia..affects is the Oxygen content of blood.(which we dont need in clinical practice!)

Lastly...anyhting that interferes mechanically with the light wavelengths (e.g red nail polish, sometime dark skin)will affect the oximeter reading.

Friday, August 27, 2010

Obstructive Sleep Apnea - More than about sleep!!


Sleep apnea has long been considered something that improves the quality of life for patients. However, it's becoming more clearer that OSA obviously has metabolic effects way more important than just helping people sleep and feel better in the morning.

Severity of OSA correlates with diabetes control. According to a study published just last December 2009 at AJRCCM, compared with patients without OSA, the adjusted mean HbA1c was increased by 1.49% in patients with mild OSA, 1.93% in patients with moderate OSA, and 3.69% in patients with severe OSA (P < 0.0001 for linear trend).

Treating heart failure patients with OSA can actually improve CHF. In the first randomized trial involving 24 patients with heart failure (EF < 45%) and moderate to severe OSA, 30 days of CPAP lowered daytime heart rate and systolic BP and increased ejection fraction by 9%. In contrast, there was no change in any of these variables in the 12 patients in the control group.

Lastly treating OSA actually helps with atherosclerosis! A small Brazilian study of 24 patients published in AJRCCM showed that 4 months of CPAP in people with OSA made a significant decrease occurred in carotid intima-media thickness, pulse-wave velocity , C-reactive protein , and catecholamines after 4 months of CPAP.

The impact of OSA on cardiovascular disease and stroke is so profound that the AHA/ACC actually produced a consensus statement about this.

So, treating OSA should be as much of a priority as those pills everybody likes prescribing!!

Wednesday, August 18, 2010

I have cavities in my lung . Im from South Africa- Can I fly?

We recently had a a lady from South Africa who came to US to visit her daughter.She is a physician in RSA in a TB clinic. She came to our ER c/o dysuria and subjective fevers. She didn't have any other symproms, and she was prescribed bactrim as urinalysis showed leucocytes & nitrites. A clever resident! did a chest Xray which showed 3-4 cavities. She is supposed to fly back to RSA the next day. This raises a few questions.

1. What is the significance of the finding of cavities in this lady ?
2. Does it need to be investigated now?
3.Can she fly back home?
4.Is there a higher chance of TB spread in a flight?

                    She is a high risk for TB ( based on work and she is from RSA). The finding of cavities in this lady is incidental. The most important point to remember is that SHE IS ASYMPTOMATIC (esp without a cough),as with regards to TB, it spreads through respiratory droplets. Cavitary TB is more infectious than other forms of TB.
As she does not have any respiratory symptoms she does not need to be investigated right now.But has to be evaluated soon ..first with a CT chest and a PPD, and then if needed, a brochoscopy.

Third....as she is asymptomatic, she is safe to fly back home. Have a look at the WHO recommendations on flying - In short.. you should not fly....if your sputum is +ve for AFB. If positive, then you should be treated for 2 weeks , and for 4 weeks in case of MDR TB before you can fly.

Forth... In 2005, CDC diagnosed 6 cases of TB in air travellrs and cabin crew, and trace down all possible contacts.This included 2900 travellers in 191 carriers.followed for a period of 3 years, only 2 of them developed TB(one was another cabin crew member, and other was a person sitting on the back row to the person with TB). So it looks like the chances of spreading TB in a flight is same as in any confined space(like in a elevator or car), and spreads only to close contacts. In both cases of TB, the flight duration was 12 hours.

So, if someone with TB has to travel, then they can do so with a little isolation, and if the flight duration is less than 8 hours.......well...provided Public Health Department is aware of this!!

Wednesday, August 11, 2010

Lung Nodule... What do I start attacking?


Major changes have been made this year on the staging system for Lung Cancer. This may cause some confusion as to the flow of patient work-up and clinical staging. The staging system is still based on the TNM system. This staging system is now based on a 10 year validation study involving 81,015 patients after exclusion of ineligible cases.

Remember that when dealing with a potential lung tumor, we should always biopsy the one that gives the highest stage. Restaging is always done once surgery has been made. This is the difference between clinical and pathologic staging.

The following changes were made:
  • There are new size cut-offs of 2, 3, 5, and 7 cm
  • T1 is divided into T1a and T1b
  • T2 is divided into T2a and T2b
  • Separate tumor nodule(s) located in the same lobe as the primary tumor are reclassified as T3, instead of T4
  • Separate tumor nodule(s) located in a different lobe of the ipsilateral lung are reclassified as T4, instead of M1
  • Malignant pleural nodules, pleural effusions, or pericardial effusions are reclassified as M1, instead of T4
This means that there are several scenarios:

1. If you have a pleural effusion, tap it. If it's malignant - Stage IV.
2. If you have another tumor on the other lung, or a lymph node on the other side (Basically anything on the other side) - Stage IIIB. No surgery.
3. If you have a tumor that invades the mediastinum, or a lymph nodes in the mediastinum or subcarinal area. - Stage IIIB. Likely not a surgical candidate. (This is where endoscopic endobronchial ultrasound has found some use).
3. Otherwise, assess as a surgical candidate, but do thorough staging first (MRI, CT, PET) to maximize your clinical staging.

Of course, after you do the surgery, you have to reassess the staging to make the staging pathology based. This is an oversimplification, but you get the idea.

Simple.

Tuesday, August 10, 2010

Doc....do I need to be admitted to ICU for this??


We had a a 48-year-old woman presented to the ER with a 48-hour history of anorexia, fever, chills, and cough and left pleuritic chest pain. On examination she looked acutely ill and seemed to be confused. Her temp was 102.2°F; HR110; RR 30; and BP 90/60 mm Hg. Sats was 89% with an infiltrate on chest xray. So the diagnosis is Community acquired pneumonia.


Can she go home? or needs admission to the floor? or needs ICU monitoring?

2 commonly used prognostic scoring systems for Community acquired pneumonia (CAP) are the Pneumonia severity Index(PSI) and the CURB 65.These were initially developed to predict mortality, but later have been used to triage patients with CAP. while PSI identifies patients with low risk of death, CURB identifies high mortality risk pts.

PSI - includes 20 variables. was developed from a cohort of nearly 140000 pts.(PORT cohort)has been validated in variety of pt. population. It divides pts into 5 classes, with class 1-3 having low mortality( 0.1 to 2.8%). class 4 & 5 had higher mortality. This does not translate into site of care decision making as nearly 27% of class 1-3 pts may end up in ICU(Eur Resp 2001).Also it doesn't take immunosupressed pts, COPD, pts with SOB etc.(e.g -a 30 yo HIV with SOB and smoking history would not be a high risk in PSI) So in triaging pts, PSI can't replace a physician's judgement, but can help to make that decision.

CURB 65 - developed and used widely in Europe,this is easy to use in ER, with scores >3 having a >20% 30-day mortality. Again,this has been translated into triage decision making, with scores 0-1 being managed as outpatients. Eventhough CURB predicted hospitalisation well in some studies(Capelastegui et al.), it can't replace clinical judgement for site of care.

So both these scores are not designed for making triage decisions,but can help clinician by providing an idea about mortality. They also are not very reliable in the elderly population.

Once decided to admit....then the need for ICU monitoring has to be determined, and again these 2 scores are not designed to do that. So ATS & IDSA have come up with a criteria ,which has sensitivity & specificity of 71% & 88% resp. for predicting ICU admission.
www.idsociety.org/WorkArea/DownloadAsset.aspx?id=9974. This is a pocket guide.

Used appropriately, these scores will help care for the needy, and at the same time save unnecessary healthcare spendng!!